These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30197602)

  • 1. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy.
    Abdulle AE; Diercks GFH; Feelisch M; Mulder DJ; van Goor H
    Front Physiol; 2018; 9():1177. PubMed ID: 30197602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.
    Ko J; Noviani M; Chellamuthu VR; Albani S; Low AHL
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.
    Zanin-Silva DC; Santana-Gonçalves M; Kawashima-Vasconcelos MY; Oliveira MC
    Front Med (Lausanne); 2021; 8():788250. PubMed ID: 35004754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.
    Ntelis K; Solomou EE; Sakkas L; Liossis SN; Daoussis D
    Semin Arthritis Rheum; 2017 Dec; 47(3):409-417. PubMed ID: 28602360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in the pathogenesis of systemic scleroderma: An overview.
    Vona R; Giovannetti A; Gambardella L; Malorni W; Pietraforte D; Straface E
    J Cell Mol Med; 2018 Jul; 22(7):3308-3314. PubMed ID: 29664231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further insight into systemic sclerosis from the vasculopathy perspective.
    Ren H; Liu L; Xiao Y; Shi Y; Zeng Z; Ding Y; Zou P; Xiao R
    Biomed Pharmacother; 2023 Oct; 166():115282. PubMed ID: 37567070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
    Silva C; Solanki KK; White DHN
    Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of B cells in systemic sclerosis.
    Kraaij MD; van Laar JM
    Biologics; 2008 Sep; 2(3):389-95. PubMed ID: 19707370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.
    Abdulle AE; van Goor H; Mulder DJ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
    Henry TW; Mendoza FA; Jimenez SA
    Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis.
    Suliman YA; Distler O
    Curr Rheumatol Rev; 2013; 9(4):237-44. PubMed ID: 26932287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis.
    Kawaguchi Y; Kuwana M
    Curr Opin Rheumatol; 2023 Nov; 35(6):309-316. PubMed ID: 37490353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
    Front Immunol; 2018; 9():1896. PubMed ID: 30177933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy.
    Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
    Life (Basel); 2021 Jun; 11(7):. PubMed ID: 34202703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.
    Pauling JD; O'Donnell VB; Mchugh NJ
    Platelets; 2013; 24(7):503-15. PubMed ID: 22966961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
    Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
    Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
    Pauling JD; Hackett N; Guida A; Merkel PA
    Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasculopathy in scleroderma.
    Asano Y; Sato S
    Semin Immunopathol; 2015 Sep; 37(5):489-500. PubMed ID: 26152638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.